SMURF2 and colorectal carcinoma: In addition, SMURF2 was reported to restrain CRC promotion via targeting SATB1, ChREBP, SIRT1, FUBP1, YY1, and RhoA as its major substrates for ubiquitination degradation [57,58,59,60,61,62].